199113-98-9 Usage
Uses
Used in Biological Research:
Balaglitazone is used as a research tool for studying the mediation of transcriptional regulatory networks. It specifically targets Musa acuminata MaDREB transcription factors, which are involved in the fruit ripening process in plants.
Used in Agricultural Applications:
In the agricultural industry, Balaglitazone is used as a tool to understand and potentially manipulate the ripening process of fruits, particularly in plants like Musa acuminata. This can lead to advancements in crop management, yield optimization, and improved fruit quality.
Used in Pharmaceutical Development:
Although not explicitly mentioned in the provided materials, Balaglitazone's interaction with transcription factors could potentially be exploited in the development of new pharmaceuticals targeting specific genetic or cellular pathways. This application would require further research and validation.
Check Digit Verification of cas no
The CAS Registry Mumber 199113-98-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,1,1 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 199113-98:
(8*1)+(7*9)+(6*9)+(5*1)+(4*1)+(3*3)+(2*9)+(1*8)=169
169 % 10 = 9
So 199113-98-9 is a valid CAS Registry Number.
199113-98-9Relevant academic research and scientific papers
Process for the preparation of thiazolidine-2,4-dione derivatives
-
, (2008/06/13)
An improved process for the preparation of 5-[4-[[3-Methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione of formula (1) which comprises: reducing the compound of formula (2′) where R represents a (C1-C4)alkyl
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
-
, (2008/06/13)
The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically accep
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
-
, (2008/06/13)
The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically accep
